Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel by Tim A. Kanters, Jelena Stevanovic, Jelena Stevanovic, Isabelle Huys, Arnold G. Vulto, Steven Simoens

Get full text

Update of the Dutch manual for costing studies in health care. by Tim A Kanters, Clazien A M Bouwmans, Naomi van der Linden, Siok Swan Tan, Leona Hakkaart-van Roijen

Get full text

Care-related Quality of Life of informal caregivers of the elderly after a hip fracture by Cornelis L. P. van de Ree, Kari Ploegsma, Tim A. Kanters, Jan A. Roukema, Mariska A. C. De Jongh, Taco Gosens

Get full text

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease by Tim A. Kanters, Ans T. van der Ploeg, Michelle E. Kruijshaar, Dimitris Rizopoulos, W. Ken Redekop, Maureen P. M. H. Rutten-van Mӧlken, Leona Hakkaart-van Roijen

Get full text